Publications
- Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis2021 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis2021 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis2021 | First Faculty of Medicine
- Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis2021 | First Faculty of Medicine
- Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis2021 | First Faculty of Medicine
- Interpretation of Brain Volume Increase in Multiple Sclerosis2021 | First Faculty of Medicine
- Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis2021 | First Faculty of Medicine
- Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis2020 | First Faculty of Medicine
- The weak association between neurofilament levels at multiple sclerosis onset and cognitive performance after 9 years2020 | First Faculty of Medicine
- Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: A longitudinal, retrospective study2020 | First Faculty of Medicine
Loading network view...
